Beryl Drugs Ltd — Important, 13-03-2026: Company Update

Beryl Drugs Limited's Promoter and Director, Sudhir Sethi, has increased his stake in the company. He acquired 15,000 equity shares via an on-market purchase, representing an additional 0.29% of the company's equity. This transaction raises his total holding from 8.98% (4,55,143 shares) to 9.27% (4,70,143 shares). This increase in promoter holding often indicates confidence in the company's future, a development typically seen as positive for shareholders.